IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms

Part of paid clinical trials in Ann Arbor, Michigan.

Sponsor
University of Michigan
Study ID
NCT06094608
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Morning light treatment — DEVICE
    Light therapy via the Re-Timer. Participants will conduct light treatment in the mornings at home for one hour using Re-timer®.
  • Treatment-as-usual — BEHAVIORAL
    Participants will not make modifications to their activities or sleep schedule.

Study Details

This research study is testing whether changes in sleep timing and morning light treatment may have an impact on symptoms related to inflammatory bowel disease.

Key Dates

Start date
Feb 1, 2024
Status verified
Apr 2026
Primary completion
Jun 30, 2027
Completion
Jun 30, 2027

Study Design

Enrollment
68 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Morning light treatment
    A 1 hour per day morning light treatment starting at average wake time, or up to 1 hour earlier to accommodate the morning schedule. The daily treatment continues for 4 weeks.
  • Active Comparator: Treatment-as-usual
    Participants will be instructed to continue to follow their usual sleep schedule for 4 weeks.

Primary Outcome Measure

Change in Short IBD Questionnaire (SIBDQ) score [ Time Frame: Baseline, post-treatment approximately 36 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of MichiganAnn ArborMichigan48105
Helen Burgess, Ph.D.
[email protected]
734-615-8303

Find similar trials in Ann Arbor, MI

By condition
Crohn's diseaseUlcerative colitis
By specialty
GastroenterologyInflammatory bowel diseaseAutoimmune disease
By research site
University of Michigan· Ann Arbor, MI

Related Studies